Impact of Proposed Tariffs and New Medicare Coverage for Obesity Drugs

This chapter analyzes the proposed 10% tariff on Chinese goods and its repercussions on U.S. imports, especially in the auto industry, while also examining immediate market reactions. Additionally, it delves into a new Biden administration proposal to include weight loss treatment drugs in Medicare and Medicaid, highlighting its potential economic implications for health policy.